Cargando…
Effect of isoflurane post-treatment on tPA-exaggerated brain injury in a rat ischemic stroke model
BACKGROUND: Intravenous tissue-type plasminogen activator (tPA) is recognized as the standard treatment for ischemic stroke. However, its narrow therapeutic window and association with an increased risk of intracranial hemorrhage have required caution when used. In this context, several approaches a...
Autores principales: | Kim, Eun Jung, Kim, So Yeon, Lee, Jae Hoon, Kim, Jeong Min, Kim, Jin-Soo, Byun, Jung Ik, Koo, Bon-Nyeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Anesthesiologists
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452673/ https://www.ncbi.nlm.nih.gov/pubmed/26045932 http://dx.doi.org/10.4097/kjae.2015.68.3.281 |
Ejemplares similares
-
Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an in vitro model of ischemic stroke
por: Cheon, So Yeong, et al.
Publicado: (2017) -
tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
por: Kim, Jong S.
Publicado: (2019) -
Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1
por: Cheon, So Yeong, et al.
Publicado: (2018) -
Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study
por: Kim, Jong S., et al.
Publicado: (2019) -
Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report
por: Kim, Chris, et al.
Publicado: (2021)